News Humacyte, Inc.

Equities

HUMA

US44486Q1031

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-19 pm EDT			5-day change	1st Jan Change
3.7 ^USD	+3.06%		+28.47%	+30.28%

Mar. 28	Transcript : Humacyte, Inc. - Special Call
Mar. 22	Transcript : Humacyte, Inc., Q4 2023 Earnings Call, Mar 22, 2024

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Humacyte, Inc. - Special Call	Mar. 28
Humacyte to Host Virtual KOL Event Hemodialysis Access, a Crossroads of Care, on March 28, 2024	Mar. 27	AQ
Humacyte to Host Virtual KOL Event “Hemodialysis Access: A Crossroads of Care,” on March 28, 2024	Mar. 26	AQ
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update	Mar. 25	AQ
Transcript : Humacyte, Inc., Q4 2023 Earnings Call, Mar 22, 2024	Mar. 22
Interest Rate, Monetary Policy Views Lift Wall Street Pre-Bell; Asia Mixed, Europe Up	Mar. 22	MT
Humacyte, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 22	CI
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update	Mar. 22	AQ
Humacyte, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 22	CI
North American Morning Briefing : Stocks Struggle After New Records	Mar. 22	DJ
Humacyte to Present 2023 Fourth Quarter and Year-End Financial Results and Provide Corporate Update on March 22, 2024	Mar. 18	AQ
Piper Sandler Adjusts Price Target on Humacyte to $4 From $3, Maintains Neutral Rating	Mar. 08	MT
Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference	Mar. 04	AQ
Humacyte Announces Proposed Public Offering of Common Stock	Mar. 01	AQ
Sector Update: Health Care Stocks Edge Higher Premarket Friday	Mar. 01	MT
Investors Await Key Economic Data, Markets Remain Flat Ahead of Opening Bell	Mar. 01	MT
Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference	Mar. 01	AQ
Humacyte Prices $40.2 Million Share Offering	Mar. 01	MT
Humacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stock	Feb. 29	AQ
Humacyte, Inc. Announces Proposed Public Offering of Common Stock	Feb. 29	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Humacyte, Inc.

Equities

HUMA

US44486Q1031

Summary

Filters